Healthcare

Healthcare Press Releases & News distributed via EuropaWire

Breast Cancer Awareness Month: bonprix strengthens women’s health advocacy with “Feel ahead!” initiative and Pink Collection

(IN BRIEF) bonprix, together with Brustkrebs Deutschland e. V., has launched its “Feel ahead!” campaign for Breast Cancer Awareness Month,…

18 hours ago

Samaritans plans 24/7 online chat and remote volunteering to strengthen its suicide prevention service

(IN BRIEF) Samaritans has announced a major programme of change to strengthen its suicide prevention service, focusing on reshaping its…

2 days ago

New Liverpool-led biosensors with AI offer low-cost solution for Alzheimer’s diagnosis worldwide

(IN BRIEF) Scientists at the University of Liverpool have developed two new handheld blood test devices that could make Alzheimer’s…

2 days ago

Tender Offer for Tourmaline Bio Shares Launched by Novartis Subsidiary Torino Merger Sub

(IN BRIEF) Novartis, through its wholly owned subsidiary Torino Merger Sub Inc., has launched a tender offer to acquire all…

4 days ago

Cosentyx Becomes First Novartis Medicine Offered at 55% Discount Through New DTP Model

(IN BRIEF) Novartis will launch a direct-to-patient (DTP) platform in the US on November 1, 2025, starting with Cosentyx, which…

4 days ago

University of Exeter and Royal Devon NHS Launch Study to Cut Delays in Diagnosing Crohn’s and Colitis

(IN BRIEF) The Royal Devon University Healthcare NHS Foundation Trust and the University of Exeter have launched the RAPID-IBD study…

4 days ago

The Institute of Cancer Research study reveals breakthrough approach to treating deadly pancreatic cancer

(IN BRIEF) The Institute of Cancer Research, London, has uncovered a promising new treatment target for pancreatic cancer, identifying the…

1 week ago

AstraZeneca and Daiichi Sankyo’s Enhertu-based regimen shows 44% risk reduction and over three-year PFS in HER2-positive metastatic breast cancer

(IN BRIEF) AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application for Enhertu plus pertuzumab has been accepted for Priority Review…

1 week ago

ECTRIMS 2025: OCREVUS confirms benefit in advanced PPMS and paediatric MS as fenebrutinib shows durable two-year results

(IN BRIEF) Roche presented new data at ECTRIMS 2025 confirming that OCREVUS provides sustained protection against disability progression and maintains…

1 week ago